1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine
2物価
選択條件:
ブランド
- Sigma-Aldrich Japan
パッケージ
- 5mg
- 生産者Sigma-Aldrich Japan
- 製品番號(hào)878115P
- 製品説明 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine, powder
- 英語(yǔ)製品説明C16-04:0 PC 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine, powder
- 包裝単位5mg
- 価格¥32200
- 更新しました2021-03-23
- 購(gòu)入
- 生産者Sigma-Aldrich Japan
- 製品番號(hào)878115C
- 製品説明 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine, chloroform
- 英語(yǔ)製品説明C16-04:0 PC 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine, chloroform
- 包裝単位5mg
- 価格¥37800
- 更新しました2023-06-01
- 購(gòu)入
生産者 | 製品番號(hào) | 製品説明 | 包裝単位 | 価格 | 更新時(shí)間 | 購(gòu)入 |
---|---|---|---|---|---|---|
Sigma-Aldrich Japan | 878115P | 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine, powder C16-04:0 PC 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine, powder |
5mg | ¥32200 | 2021-03-23 | 購(gòu)入 |
Sigma-Aldrich Japan | 878115C | 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine, chloroform C16-04:0 PC 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine, chloroform |
5mg | ¥37800 | 2023-06-01 | 購(gòu)入 |
プロパティ
貯蔵溫度 :Store at -20°C
溶解性 :DMF: 14 mg/ml; DMSO: 12 mg/ml; Ethanol: 30 mg/ml; PBS (pH 7.2): 5 mg/ml
外見(jiàn) :powder
溶解性 :DMF: 14 mg/ml; DMSO: 12 mg/ml; Ethanol: 30 mg/ml; PBS (pH 7.2): 5 mg/ml
外見(jiàn) :powder
安全情報(bào)
絵表示(GHS): | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
注意喚起語(yǔ): | Danger | ||||||||||||||||||||||||||||||
危険有害性情報(bào): |
|
||||||||||||||||||||||||||||||
注意書(shū)き: |
|
説明
Oxidized low-density lipoprotein (oxLDL) particles contain low molecular weight species which promote the differentiation of monocytes and activate polymorphonuclear leukocytes. One of these substances was recently isolated and purified from oxLDL, and identified as azelaoyl PC. Butanoyl PAF is a closely related compound which retains at least 10% of the agonist potency of platelet-activating factor (PAF) itself. Further, butanoyl PAF is present in oxLDL in amounts more than 100 times greater than enzymatically generated PAF. Butanoyl PAF is therefore one of the important signalling molecules present in oxLDL.供給者とメーカー
Creative Enzymes
Codow Chemical Co.,Ltd.
Shanghai EFE Biological Technology Co., Ltd.
Chengdu Dianchun Technology Co., Ltd
Shanghai Hongye Biotechnology Co. Ltd
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
MedBioPharmaceutical Technology Inc
Shanghai Haohong Scientific Co., Ltd.
TargetMol Chemicals Inc.
Hubei Danding Pharmaceutical Technology Co., Ltd